期刊文献+

胸腺瘤术后生存期的相关影响因素分析 被引量:1

下载PDF
导出
摘要 【目的】探讨影响胸腺瘤术后生存期的相关因素。【方法】选择2003年1月至2007年2月于本院行手术治疗的胸腺瘤患者127例为研究对象,随访至今。收集患者临床资料,选取患者的临床表现、WHO组织学分型、临床切除状态、手术切除范围、有无合并重症肌无力、Masaoka分期,疾病是否进展或是否死亡等指标为影响患者术后生存期的因素,并对其进行单因素及多因素非条件Logistics回归分析。【结果】127例患者,死亡10例,男6例,女4例。死亡患者WHO组织学分型B2型1例、B3型2例、C型7例;Masaoka分期Ⅰ期1例、Ⅱ期2例、Ⅲ期7例,合并重症肌无力7例;临床切除状态R0为2例、R1为3例、R2为5例;单纯胸腺切除6例、胸腺加纵隔脂肪切除3例、胸腺加纵隔脂肪和心包垫切除1例。单因素分析显示手术切除范围、肿块大小、WHO组织学分型、Masaoka分期、临床切除状态以及合并重症肌无力与无进展生存期(PFS)、总生存数(OS)存在显著相关(P〈0.05),年龄与OS显著相关(P〈0.05);全切的Ⅱ期胸腺瘤中,术后辅助性放疗对OS和PFS均无影响(P〉0.05)。非条件Logistic回归分析显示:手术切除范围、肿块大小、WHO组织学分型、Masaoka分期、临床切除状态以及合并重症肌无力与PFS存在显著相关,且为OS预测因素(P〈0.05)。【结论】胸腺加纵隔心包垫切除、肿块大、Masaoka分期、WHO组织学分型、临床切除状态、合并重症肌无力是胸腺瘤患者主要的预测因素;且对于Ⅱ期胸腺全切患者术后放疗并无延迟生存期的作用。
出处 《医学临床研究》 CAS 2018年第4期808-811,共4页 Journal of Clinical Research
  • 相关文献

参考文献3

二级参考文献41

  • 1Maggi G, Casadio C, Cavallo A, et al. Tnymoma: results of 241 operated cases. Ann 2-horac Surg, 1991, 51(1): 152-156.
  • 2Okumura M, Miyoshi S, Takeuchi Y~ et al. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg, 1999, 117(3): 605-613.
  • 3de Perrot M, LiuJ, Bril V, et al. Prognostic significance of thymomas in patients with myasthenia gravis. Ann Thorac Surg, 2002, 74(5): 1658-1662.
  • 4Maggi G, Casadio C, Cavallo A, et al. 2hymectomy in myasthenia gravis. Results of 662 cases operated upon in 15 years. EurJ Cardiothorac Surg, 1989, 3(6): 504-509.
  • 5Kondo K, Monden Y. Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan. Ann Thorac Surg, 2005, 79(1): 219-224.
  • 6Ruffini E, Filosso PL, Mossetti C, et al. Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience. EurJ Cardiothorac Surg, 2011, 40(1): 146-153.
  • 7Filosso PL, Venuta F, Oliaro A, et al. Taymoma and inter-relationships between clinical variables:amulticentre study in 537 patients. EurJ Cardiothorac Surg, 2014, 45(6): 1020-1027.
  • 8Girard N, Mornex F, Van Houtte P, et al. Thymoma: a focus on current therapeutic management. J qqaorac Oncol, 2009, 4(1): 119-126.
  • 9Masaoka-Koga A, Monden Y, Nakahara K, et al. Follow-up study of Thymic tumors with special reference to their clinical stages. Cancer, 1981, 48(11): 2485-2492.
  • 10Detterbeck FC, Nicholson AG, Kondo K, et al. The Masaoka-Koga-Koga stage classification for thymic malignancies: clarification and definition of terms.J Thorac Oncol, 2011, 6(7 Suppl 3): S1710-$1716.

共引文献31

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部